Concord Biotech Limited announced the appointment of Mr. Raviraj Karia as the new Chief Financial Officer (CFO) of the company. This appointment was approved by the Board of Directors in their meeting held on Thursday, December 18, 2025, following recommendations from the Nomination and Remuneration Committee and the Audit Committee. Mr. Karia's appointment is effective from December 18, 2025. He is a Chartered Accountant with over 23 years of experience in finance across pharmaceuticals, healthcare, clinical research, logistics, and private equity. His expertise includes corporate governance, strategic finance, and business partnering. He has previously held leadership roles at companies such as Intas Pharmaceuticals, Sakar Healthcare, and Gati. The Board meeting commenced at 12:10 PM and concluded at 12:50 PM. Mr. Karia is not related to any of the Directors of the Company and holds no shares in the company.